The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Multiple Antibiotic Resistance in Stenotrophomonas maltophilia : Involvement of a Multidrug Efflux System
Open accessAbstract
Clinical strains of Stenotrophomonas maltophilia are often highly resistant to multiple antibiotics, although the mechanisms of resistance are generally poorly understood. Multidrug resistant (MDR) strains were readily selected by plating a sensitive reference strain of the organism individually onto a variety of antibiotics, including tetracycline, chloramphenicol, ciprofloxacin, and norfloxacin. Tetracycline-selected MDR strains typically showed cross-resistance to erythromycin and fluoroquinolones and, in some instances, aminoglycosides. MDR mutants selected with the other agents generally displayed resistance to chloramphenicol and fluoroquinolones only, although two MDR strains (e.g., K1385) were also resistant to erythromycin and hypersusceptible to aminoglycosides. Many of the MDR strains expressed either moderate or high levels of a novel outer membrane protein (OMP) of ca. 50 kDa molecular mass, a phenotype typical of MDR strains of Pseudomonas aeruginosa hyperexpressing drug efflux systems. Indeed, the 50-kDa OMP of these S. maltophilia MDR strains reacted with antibody to OprM, the outer membrane component of the MexAB-OprM MDR efflux system of P. aeruginosa . Similarly, a ca. 110-kDa cytoplasmic membrane protein of these MDR strains also reacted with antibody to the MexB component of the P. aeruginosa pump. The outer and cytoplasmic membranes of several clinical S. maltophilia strains also reacted with the anti-OprM and anti-MexB antibodies. N-terminal amino acid sequencing of a cyanogen bromide-generated peptide of the 50-kDa OMP of MDR strain K1385, dubbed SmeM ( Stenotrophomonas multidrug efflux), revealed it to be very similar to a number of outer membrane multidrug efflux components of P. aeruginosa and Pseudomonas putida . Deletion of the L1 and L2 β-lactamase genes confirmed that these enzymes were responsible for the bulk of the β-lactam resistance of K1385 and its parent. Still, overexpression of the MDR efflux mechanism in an L1- and L2-deficient derivative of K1385 did yield a modest increase in resistance to a few β-lactams. These data are consistent with the MDR efflux mechanism(s) playing a role in the multidrug resistance of S. maltophilia .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nikaido, H., Basina, M., Nguyen, V., & Rosenberg, E. Y. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.17.4686-4692.1998 · Cited by 224 · cited 4×
“128 16 128 128 K1432 TET (30) 8 8 16 16 1,024 K1433 TET (30) 8 8 4 16 1,024 K1434 NOR (30) 4 64 16 64 128 K1435 NOR (30) 8 128 16 128 128 K1436 CIP (1) 4 64 16 128 128 K1437 CIP (8) 4 64 16 128 128 ULA-511 8 8 4 16 512 K1438 CAM (20) 8 64 32 128 512 K1439 CAM (20) 16 64 .”
BackgroundInfluential
Cited by
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Self-citationStenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
Brooke, J. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-11 · Cited by 1,434
Tamma, P. D., Heil, E. L., Justo, J. A., Mathers, A. J., Satlin, M. J., & Bonomo, R. A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae403 · Cited by 1,191
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Self-citationEfflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Self-citationTamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad428 · Cited by 740
Efflux-mediated multiresistance in Gram-negative bacteria
Poole, K. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00763.x · Cited by 613
Self-citationStenotrophomonas maltophilia: an emerging opportunist human pathogen
Looney, W. J., Narita, M., & Mühlemann, K. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70083-0 · Cited by 550
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab1013 · Cited by 519
Gales, A. C., Jones, R. N., Forward, K. R., Liñares, J., Sader, H. S., & Verhoef, J. (2001) · Clinical Infectious Diseases · doi:10.1086/320183 · Cited by 441
Involvement of a Novel Efflux System in Biofilm-Specific Resistance to Antibiotics
Zhang, L., & Mah, T.-F. (2008) · Journal of Bacteriology · doi:10.1128/jb.01655-07 · Cited by 385
Self-citationEfflux-Mediated Resistance to Fluoroquinolones in Gram-Negative Bacteria
Poole, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2233-2241.2000 · Cited by 371
Self-citationAdegoke, A. A., Stenström, T. A., & Okoh, A. I. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02276 · Cited by 301
Multidrug resistance in Gram-negative bacteria
Poole, K. (2001) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00242-3 · Cited by 275
Self-citationInteraction of Oral and Toothbrush Microbiota Affects Oral Cavity Health
Shang, Q., Gao, Y., Qin, T., Wang, S., Shi, Y., & Chen, T. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00017 · Cited by 39
Metadata
- Authors
- Zhang, L., Li, X.-Z., & Poole, K.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2000-02
- Volume
- 44
- Issue
- 2
- Pages
- 287-293
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2119490092
- Cited by
- 190
- References
- 1
- FWCI
- 9.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.